• EN

    • -+ 0.00%
    -+ 0.00%
    -+ 0.00%

    Baxter International (BAX) Could Be 5% Undervalued After Profit Return And Higher Outlook

    Simply Wall St·11/09/2026 14:20:21
    Listen to the news

    Baxter International (BAX) just posted third quarter results that moved from a loss to a profit and raised its 2026 sales growth outlook from 3% to 4% and up to 4% to 5%.

    Baxter International’s latest guidance hike and return to profitability arrive alongside a 7 day share price return of 12.13% and a year to date gain of 32.26%. The 1 year total shareholder return of 43.55% contrasts with weaker 3 and 5 year total returns, suggesting improving momentum from a low base.

    Scan beyond Baxter International and see how it stacks up against a hand picked 40 high quality undervalued stocks that also combine improving earnings profiles with solid business fundamentals.

    Baxter International’s sharp rebound, backed by fresh profits and higher sales guidance, could be read as improving business health rather than just a sentiment swing. How far does the current valuation already reflect that shift?

    Most Popular Narrative: 5% Undervalued

    At a last close of $25.79 against the analyst consensus Narrative fair value of $27.08, Baxter International screens as modestly undervalued, with that view built on detailed assumptions about revenue, margins and cash flows in the analyst consensus Narrative on Simply Wall St.

    Analysts expect earnings to reach $829.1 million (and earnings per share of $1.65) by about November 2029, up from -$619.0 million today. However, there is a considerable amount of disagreement amongst the analysts, with the most bullish expecting $1.5 billion in earnings and the most bearish expecting $598.5 million.

    See why 20 investors see Baxter International as 5% undervalued.

    Result: Fair Value of $27.08 (UNDERVALUED)

    Still, the narrative can unravel if Novum IQ pump field actions drag on or if FDA manufacturing concerns at Baxter International’s injectable facility prove harder to resolve.

    Find out about the key risks to this Baxter International narrative.

    Next Steps

    Mixed signals in the Baxter International story make this a moment to check the numbers yourself and decide how convincing the current setup really feels. To weigh both sides quickly and build your own view, start with the 3 key rewards and 1 important warning sign.

    Looking for more investment ideas beyond Baxter International?

    If Baxter International has sharpened your focus, do not stop here. Broaden your watchlist now and give yourself more options before the next move.